⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Mesenchymal Stromal/Stem Cell Joint Therapies
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-04-02 — Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.: cross-connection with ginsenosides: Rg1 augments mesenchymal stem cell abundance in exercised aging muscle, linking a TCM bioactive to the MSC-rejuvenation axis explored under stem cell therapies. (novelty: 3)
Open questions
Related
Contributing findings
Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.
10-aug-2026
novelty 3
per-area 2
mentions